c
27
1f0
8
3a
8
4f
16
c
f
19
1
49
2
8
8
28
11
1b
1d
18
79
3b
1d
2 29
1d
25
3b
Brian T. Fisher, DO, MSCE, MPH
7dProfessor of Pediatrics (Infectious Diseases) at the Children's Hospital of Philadelphia
7
61
Department: Pediatrics
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
52
4
3
3
1d
52
Children's Hospital of Philadelphia
28 Division of Infectious Diseases
19 2716 South Street
3d Roberts Center, Room 10362
Philadelphia, PA 19146
26
28 Division of Infectious Diseases
19 2716 South Street
3d Roberts Center, Room 10362
Philadelphia, PA 19146
2e
Office: 267-426-7110
27 Fax:
24
87
27 Fax:
24
Email:
fisherbria@chop.edu
12
fisherbria@chop.edu
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 9 B.S. 14 (Biology) c
31 University of Notre Dame, 1995.
21 b M.P.H. 19 (Epidemiology) c
3a University of Illinois at Chicago, 1998.
21 9 D.O. 21 (Osteopathic Medicine) c
56 Midwestern University-Chicago College of Osteopathic Medicine, 2002.
21 d M.S.C.E. 2b (Epidemiology and Biostatistics) c
33 University of Pennsylvania, 2009.
c
3
27
21 9 B.S. 14 (Biology) c
31 University of Notre Dame, 1995.
21 b M.P.H. 19 (Epidemiology) c
3a University of Illinois at Chicago, 1998.
21 9 D.O. 21 (Osteopathic Medicine) c
56 Midwestern University-Chicago College of Osteopathic Medicine, 2002.
21 d M.S.C.E. 2b (Epidemiology and Biostatistics) c
33 University of Pennsylvania, 2009.
c
Links
e1 Search PubMed for articles
c3 Profile of current research activity within the Pediatric IDEAS Research Group
c
5
3
3
92
Permanent linke1 Search PubMed for articles
c3 Profile of current research activity within the Pediatric IDEAS Research Group
c
2 29
21
1e
1d
24
5a
e 29
27
Description of CCEB Expertise
26d Dr. Fisher is a pharmacoepidemiologist with particular interest in optimizing the diagnosis, prevention and management of opportunistic infections in immunocompromised hosts. He currently serves as the Chair of the Infectious Disease Committee of the Children’s Oncology Group and co-Director of the International Pediatric Fungal Network. In these positions he helps design and perform large multicenter observational studies and randomized controlled trials in immunocompromised patient populations, specifically in children with leukemia and those undergoing hematopoietic stem cell transplantation.e 29
23
fc Luan X, Fisher B, Coffin S, Rubin D, Matone M, Huang J: School masking and COVID-19 community transmission: a synthetic control study. Health Affairs Scholar 3(12), December 2025.
1a2 Zheng DJ, Hettinger G, Bender JD, Boulter AC, Cao L, Elgarten CW, Fisher BT, Gathers C, Huang YV, Ko J, Leger KJ, Li Y, Myers R, Narayan HK, Ortiz J, Seif AE, Vasileiadi E, Aplenc R, Getz KD: National Trends in Dexrazoxane and Cardiovascular Health Care Utilization for Children With Acute Myeloid Leukemia. JAMA Oncol 11(12): 1545-48, Dec 2025.
11d Vasileiadi E, Elgarten CW, Getz KD, Aplenc R, Fisher BT: Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients With Hematologic Malignancy. J Pediatric Infect Dis Soc 14(10), Oct 2025.
140 Vasileiadi E, Elgarten CW, Getz KD, Aplenc R, Fisher BT: Fluoroquinolone Susceptibility and Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients With Hematologic Malignancy. J Pediatric Infect Dis Soc 14(10), Oct 2025.
1c9 Ladas EJ, Collier W, Park H, Auletta JJ, Dvorak CC, August A, Esbenshade AJ, Bhatia M, Fisher BT, Levine JE, Pollock BH, Uhlemann AC, Verneris MR, Walters M, Yu L, Nieder M: A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633). Transplant Cell Ther 31(7): 452.e1-452.e12, Jul 2025.
23e Blumenstock JA, Faerber JA, Menon M, Lawler R, Downes KJ, Kratz E, Erickson K, Haltzman-Cassenti B, Yildirim I, Hussaini L, Elmontser M, Sederdahl BK, Hahn A, Thomson J, Newland J, Terrill C, Bradley J, Zachariah P, Younus M, Mo J, Wible M, Tawadrous M, Fisher BT: Leveraging real-world Data from administrative claims and medical records to inform safety and effectiveness of piperacillin-tazobactam in the Management of Pediatric Hospital Acquired Pneumonia. Am J Epdemiol 194(5): 1426-35, May 2025.
10a Grasty MA, L'Etoile N, Nitsche LJ, Takeda M, Fisher BT, Drant S, Mavroudis CD: Aortic Rupture in a Pediatric Patient With Influenza. World J Pediatr Congenit Heart Surg 16(1): 130-32, Jan 2025.
20a Seif AE, McDonough SL, Becker-Haimes EM, Oranges KE, Clerico D, Hartman J, Rodock K, Schwartz LA, Elgarten CW, Myers RM, Puszczynski RO, Rheingold SR, Stern JW, Jubelirer TF, Armideo EA, Evageliou NF, Randall RJ, Bernt KM, Reilly AF, Tasian SK, Diamant RK, Fisher BT, Getz KD, Aplenc R: AML Care at Home: An Evidence-Based Toolkit to Personalize the Care Setting for Recovery From Pediatric AML Chemotherapy. JOC Oncol Pract epub ahad of print 2025.
312 Bucayu RFT, Boge CLK, Yildirim I, Avilés-Robles M, Vora SB, Berman DM, Sharma TS, Sung L, Castagnola E, Palazzi DL, Danziger-Isakov L, Yin DE, Roilides E, Maron G, Tribble AC, Soler-Palacin P, López-Medina E, Romero J, Belani K, Arrieta AC, Carlesse F, Nolt D, Halasa N, Dulek D, Rajan S, Muller WJ, Ardura MI, Pong A, Gonzalez BE, Salvatore CM, Huppler AR, Aftandilian C, Abzug MJ, Chakrabarti A, Green M, Lutsar I, Knackstedt ED, Johnson SK, Steinbach WJ, Fisher BT, Wattier RL: Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network. J Pediatric Infect Dis Soc 13(12): 633-38, Dec 2024.
2c
7
1d
1f
Selected Publications
13b Chiusaroli L, Boustany M, Millimono JK, Blumenstock J, Boge CLK, Zalot MA, Fisher BT: Describing the Utility of Fungal Blood Cultures in Patients Hospitalized at a Large Pediatric Academic Center. Pediatric Inf Dis J epub ahead of print 2026.fc Luan X, Fisher B, Coffin S, Rubin D, Matone M, Huang J: School masking and COVID-19 community transmission: a synthetic control study. Health Affairs Scholar 3(12), December 2025.
1a2 Zheng DJ, Hettinger G, Bender JD, Boulter AC, Cao L, Elgarten CW, Fisher BT, Gathers C, Huang YV, Ko J, Leger KJ, Li Y, Myers R, Narayan HK, Ortiz J, Seif AE, Vasileiadi E, Aplenc R, Getz KD: National Trends in Dexrazoxane and Cardiovascular Health Care Utilization for Children With Acute Myeloid Leukemia. JAMA Oncol 11(12): 1545-48, Dec 2025.
11d Vasileiadi E, Elgarten CW, Getz KD, Aplenc R, Fisher BT: Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients With Hematologic Malignancy. J Pediatric Infect Dis Soc 14(10), Oct 2025.
140 Vasileiadi E, Elgarten CW, Getz KD, Aplenc R, Fisher BT: Fluoroquinolone Susceptibility and Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients With Hematologic Malignancy. J Pediatric Infect Dis Soc 14(10), Oct 2025.
1c9 Ladas EJ, Collier W, Park H, Auletta JJ, Dvorak CC, August A, Esbenshade AJ, Bhatia M, Fisher BT, Levine JE, Pollock BH, Uhlemann AC, Verneris MR, Walters M, Yu L, Nieder M: A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633). Transplant Cell Ther 31(7): 452.e1-452.e12, Jul 2025.
23e Blumenstock JA, Faerber JA, Menon M, Lawler R, Downes KJ, Kratz E, Erickson K, Haltzman-Cassenti B, Yildirim I, Hussaini L, Elmontser M, Sederdahl BK, Hahn A, Thomson J, Newland J, Terrill C, Bradley J, Zachariah P, Younus M, Mo J, Wible M, Tawadrous M, Fisher BT: Leveraging real-world Data from administrative claims and medical records to inform safety and effectiveness of piperacillin-tazobactam in the Management of Pediatric Hospital Acquired Pneumonia. Am J Epdemiol 194(5): 1426-35, May 2025.
10a Grasty MA, L'Etoile N, Nitsche LJ, Takeda M, Fisher BT, Drant S, Mavroudis CD: Aortic Rupture in a Pediatric Patient With Influenza. World J Pediatr Congenit Heart Surg 16(1): 130-32, Jan 2025.
20a Seif AE, McDonough SL, Becker-Haimes EM, Oranges KE, Clerico D, Hartman J, Rodock K, Schwartz LA, Elgarten CW, Myers RM, Puszczynski RO, Rheingold SR, Stern JW, Jubelirer TF, Armideo EA, Evageliou NF, Randall RJ, Bernt KM, Reilly AF, Tasian SK, Diamant RK, Fisher BT, Getz KD, Aplenc R: AML Care at Home: An Evidence-Based Toolkit to Personalize the Care Setting for Recovery From Pediatric AML Chemotherapy. JOC Oncol Pract epub ahad of print 2025.
312 Bucayu RFT, Boge CLK, Yildirim I, Avilés-Robles M, Vora SB, Berman DM, Sharma TS, Sung L, Castagnola E, Palazzi DL, Danziger-Isakov L, Yin DE, Roilides E, Maron G, Tribble AC, Soler-Palacin P, López-Medina E, Romero J, Belani K, Arrieta AC, Carlesse F, Nolt D, Halasa N, Dulek D, Rajan S, Muller WJ, Ardura MI, Pong A, Gonzalez BE, Salvatore CM, Huppler AR, Aftandilian C, Abzug MJ, Chakrabarti A, Green M, Lutsar I, Knackstedt ED, Johnson SK, Steinbach WJ, Fisher BT, Wattier RL: Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network. J Pediatric Infect Dis Soc 13(12): 633-38, Dec 2024.
2c